What Is Atlas Compliance, and How Does It Help Pharma and Medical Device Companies?

In pharma and medical devices, FDA compliance isn't just a responsibility. It's the function that determines whether your company can sell its products. Per FDA data, 62% of drugs that entered shortage between 2013 and 2017 were tied to manufacturing or product quality problems. Warning letters freeze new drug approvals. Careers end over bad inspections.

Quality teams need comprehensive, current FDA inspection and enforcement data structured for their specific situation. This post covers what Atlas is, what's inside it, and how quality teams use it.

What Is Atlas?

Atlas is an FDA inspection and enforcement intelligence platform for pharma and medical device quality teams. It gives quality teams complete, current FDA data, structured and searchable for their specific use case.

The database covers:

• 700,000+ FDA inspections since 2010
• 30,000+ Form 483s and EIRs (Establishment Inspection Reports)
• 11,828 warning letters since 2008
• ~500 Complete Response Letters (CRLs)
• 100,000+ searchable observations
• 6,000+ investigator reports showing focus areas, citation patterns, and how they've evolved
• Import alerts, recalls, and debarment letters
• International agency data from MHRA (UK), PMDA (Japan), Health Canada, CDSCO (India), and Swissmedic

If Atlas doesn't have the data you're looking for, nobody does.

How Quality Teams Use Atlas

1. Access to Historical Data

Atlas gives quality teams a comprehensive repository of past FDA inspection reports, including 483s, EIRs, warning letters, and recalls. You can search by:

• Company name
• Category (drug manufacturing, medical devices, biologics)
• Country
• Investigator name
• CFR code
• Site type (API, sterile injectable, formulation)
• Keyword

If a competitor gets a warning letter for documentation gaps, your team can pull the full observations, see which CFR codes got cited, and audit your own records against that pattern before an investigator walks in.

2. Custom Analytics

Atlas builds custom analytics rapidly for your exact use case, at no extra cost. For example:

• Which CFR codes are getting cited most at companies like yours?
• What are specific investigators focusing on, and how have their patterns shifted year over year?
• How do your top 200 suppliers compare on inspection history?

The legacy alternative offers predetermined reports. Atlas builds what you actually need.

3. Inspection Preparation

The moment a quality team learns who's assigned to their site, they search the investigator by name. Atlas pulls up the full inspection history, focus areas by CFR code, citation patterns, and trend evolution. 6,000+ investigator reports are available.

Quality teams can also study the inspection history of peer companies, anticipate likely focus areas, and build CAPAs that reference how similar observations were resolved elsewhere.

4. Supply Chain and Peer Monitoring

Upload your supplier and external manufacturer list. Atlas sends email or WhatsApp alerts when any of them gets inspected, receives a 483, or gets a warning letter. If your supplier tells you everything is fine, Atlas lets you verify it independently.

5. AI Copilot

Ask natural-language questions about any investigator, observation, or CFR code, in any language. The copilot returns color-coded breakdowns (primary, secondary, tertiary issues) so your team can act on dense regulatory language in minutes instead of hours.

Atlas

See what the FDA knows about your next investigator.

30 minutes with the founder. No pitch deck.

See it live

Why Compliance Matters

The cost of non-compliance is high. FDA enforcement is accelerating: FY2025 saw 694 more inspections than FY2024, and H2 2025 alone produced 327 warning letters, a 73% increase. Through May 2024, 94 of 114 FDA pilot inspections in India were unannounced; in May 2025 this expanded into a permanent global program.

Non-compliance can lead to:

• Warning letters (which freeze new drug approvals)
• Product recalls
• Import alerts (facility-specific)
• Consent decrees
• Loss of customer and investor trust

Why Atlas

Atlas stands apart in four ways:

• Complete data. 700,000+ inspections since 2010. If we don't have it, nobody does.
• Fresh data. Inspection data typically arrives on Atlas within a business week of an inspection occurring, through proprietary market intelligence. That's before it appears on the FDA website or competing platforms.
• Custom analytics. Built rapidly for your exact use case, not predetermined reports.
• Direct engineering support. Feature requests go to the people who build the product. No account managers, no support tiers.

Atlas is used by quality teams at J&J, Kenvue, Bayer, Zydus, Cipla, Grifols, and dozens more.